Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease

International Journal of Cancer

Volumn 68, Issue 3, 1996, Pages 285-290

  Chiang, Alan K S ^a   Tao, Qian ^a,b   Srivastava, Gopesh ^c   Ho, Faith C S ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; NASOPHARYNX CARCINOMA; NOSE TUMOR; PRIORITY JOURNAL; T CELL LYMPHOMA; VIRUS LATENCY;

DNA-BINDING PROTEINS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION; GENES, VIRAL; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; NASOPHARYNGEAL NEOPLASMS; POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEINS; RNA, MESSENGER; RNA-BINDING PROTEINS; T-LYMPHOCYTES; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; VIRAL MATRIX PROTEINS; VIRAL PROTEINS; VIRUS LATENCY;

EID: 0029850091     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961104)68:3<285::AID-IJC3>3.0.CO;2-Y     Document Type: Article

References (37)

1. BROOKS, L., YAO, Q.Y., RICKINSON, A.B. and YOUNG, L.S., Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J. Virol., 66, 2689-2697 (1992).
2. CHANG, Y.-S., SU, I.-J., CHUNG, P.-J., SHU, C.-H., NG, C.-K., WU, S.-J. and LIU, S.-T., Detection of an Epstein-Barr-virus variant in T-cell- lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in the Taiwanese population. Int. J. Cancer, 62, 673-677 (1995).
3. CHEN, C.-L., SADLER, R.H., WALLING, D.M., SU, I.-J., HSIEH, H.-C. and RAAB-TRAUB, N., Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. J. Virol., 67, 6303-6308 (1993).
4. CHIANG, A.K.S., SRIVASTAVA, G., LAU, P.W.F. and HO, F.C.S., Differences in T-cell-receptor gene rearrangement and transcription in nasal lymphomas of natural killer and T-cell-types: implications on cellular origin. Hum. Pathol. 27, 701-707 (1996).
5. DEACON, E.M., PALLESEN, G., NIEDOBITEK, G., CROCKER, J., BROOKS, L., RICKINSON, A.B. and YOUNG, L.S., Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J. exp. Med., 177, 339-349 (1993).
6. FAHRAEUS, R., RYMO, L, RHIM, J.S. and KLEIN, G., Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature (Lond.), 345, 447-449 (1990).
7. FELLBAUM, C., HANSMANN, M.-L. and LENNERT, K., Malignant lymphomas of the nasal cavity and paranasal sinuses. Virchows Archiv. A Pathol. Anat., 414, 399-405 (1989).
8. HARABUCHI, Y., YAMANAKA, N., AKIKATSU, K., IMAI, S., KINOSHITA, T., MIZUNO, M. and OSATO, T., Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet, 335, 128-130 (1990).
9. HENDERSON, S., HUEN, D., ROWE, M., DAWSON, C., JOHNSON, G. and RICKINSON, A., Epstein-Barr virus-encoded BHRF1 protein, a viral homologue of Bel-2, protects human B cells from programmed cell death. Proc. nat. Acad. Sci. (Wash.), 90, 8479-8483 (1993).
10. Ho, F.C.S., CHOY, D., LOKE, S.L., KUNG, I.T.M., FU, K.H., LIANG, R., TODD, D. and KHOO, R.K.K., Polymorophic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: a clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases. Hunt. Pathol., 21, 1041-1050 (1990a).
11. HO, F.C.S., SRIVASTAVA, G., LOKE, S.L., FU, K.H., LEUNG, B.P.Y., LIANG, R. and CHOY, D., Presence of Epstein-Barr virus DNA in nasal lymphomas of B and T cell type. Hematol. Oncol., 8, 271-281 (1990b).
12. HO, F.C.S., TODD, D., LOKE, S.L., NG, R.P. and KHOO, R.K.K., Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients, retrospective study covering an eight-year period. Int. J. Cancer, 34, 143-148 (1984).
13. HU, L.-F., CHEN, F., ZHENG, X., ERNBERG, I., CAO, S.-L., CHRISTENSSON, B., KLEIN, G. and WINBERG, G., Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene, 8, 1575-1583 (1993).
14. HU, L.-F., ZABAROVSKY, E.R., CHEN, F., CAO, S.-L., ERNBERG, I., KLEIN, G. and WINBERG, G., Isolation and sequencing of the EpsteinBarr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J gen. Virol., 72, 2399-2409 (1991).
15. JAFFE, E.S., CHAN, J.K.C., SU, I.-J., FRIZZERA, G., MORI, S., FELLER, A.C. and Ho, F.C.S., Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas: definitions, differential diagnosis, and epidemiology. Amer. J. surg. Pathol., 20, 103-111 (1996).
16. KERR, B.M., LEAR, A.L., ROWE, M., CROOM-CARTER, D., YOUNG, L.S., ROOKES, S.M., GALLIMORE, P.H. and RICKINSON, A.B., Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage. Virology, 187, 189-201 (1992).
17. KIEFF, E. and LIEBOWITZ, D., Epstein-Barr virus and its replication. In: B.N. Fields and D.M. Knipe (eds.), Fields virology (2nd ed.), pp. 1889-1920, Raven Press, New York (1990).
18. KLEIN, G., Epstein-Barr virus strategy in normal and neoplastic B cells. Cell, 77, 791-793 (1994).
19. KNECHT, H., BACHMANN, E., BROUSSET, P., ROTHENBERGER, S., EINSELE, H., LESTOU, V.S., DELSOL, G., BACHMANN, F., AMBROS, P.F. and ODERMATT, B. F., Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders. Oncogene, 10, 523-528 (1995).
20. KNECHT, H., BACHMANN, E., BROUSSET, P., SANDVEJ, K., NADAL, D., BACHMANN, F., ODERMATT, B.F., DELSOL, G. and PALLESEN, G., Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood, 82, 2937-2942 (1993).
21. LEAR, A.L., ROWE, M., KURILLA, M.G., LEE, S., HENDERSON, S., KIEFF, E. and RICKINSON, A.B., The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle. J Virol., 66, 7461-7468 (1992).
22. LONGNECKER, R., MILLER, C.L., MIAO, X.Q., TOMKINSON, B. and KIEFF, E., The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensible for lymphocyte infection and growth transformation in vitro. J. Virol., 67, 2006-2013 (1993).
23. MlNAROVITS, J., HU, L.F., IMAI, S., HARABUCHI, Y., KATAURA, A., MINAROVITS-KORMUTA, S., OSATO, T. and KLEIN, G., Clonality, expression and methylation of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas. J. gen. Virol., 75, 77-84 (1994).
24. MINAROVITS, J., MINAROVITS-KORMUTA, S., EHLIN-HENRIKSSON, B., FALK, K., KLEIN, G. and ERNBERG, I., Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA. J. gen. Virol., 72, 1591-1599 (1991).
25. MURRAY, R.J., KURILLA, M.G., BROOKS, J.M., THOMAS, W.A., ROWE, M., KIEFF, E. and RICKINSON, A.B., Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J. exp. Med., 176, 157-168 (1992).
26. NIEDOBITEK, G., AGATHANGGELOU, A., ROWE, M., JONES, D.B., TURYAGUMA, P., ORYEMA, J., WRIGHT, D.H. and YOUNG, L.S., Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma. Blood, 86, 659-665 (1995).
27. OUDEJANS, J.J., JIWA, M., VAN DEN BRULE, A.J.C., GRASSER, F.A., HORSTMAN, A., VOS, W., KLUIN, P.M., VAN DER VALK, P., WALBOOM- ERS, J.M.M. and MEIJER, C.J.L.M., Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders. Amer. J. Pathol., 147, 923-933 (1995).
28. PENG, M. and LUNDGREN, E., Transient expression of the EpsteinBarr virus LMP1 gene in B-cell chronic lymphocytic luekemia cells, T cells and hematopoietic cell lines: cell-type-independent induction of CD23, CD21, and ICAM-1. Leukemia, 7, 104-112 (1993).
29. ROBERTSON, E.S., TOMKINSON, B. and KIEFF, E., An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARFO transforms B lymphocytes in vitro. J. Virol., 68, 1449-1458 (1994).
30. ROWE, M., ROWE, D.T., GREGORY, C.D., YOUNG, L.S., FARRELL, P.J., RUPANI, H. and RICKINSON, A.B., Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J., 6, 2743-2751 (1987).
31. SCHAEFER, B.C., STROMINGER, J.L. and SPECK, S.H., The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA1 gene transcription in group 1 Burkitt's lymphoma cell lines. J Virol., 69, 5039-5047 (1995).
32. TAO, Q., HO, F.C.S., LOKE, S.L. and SRIVASTAVA, G., Epstein-Barr virus is localized in the tumour cells of nasal lymphomas of NK, T or B cell type. Int. J. Cancer, 60, 315-320 (1995a).
33. TAO, Q., SRIVASTAVA, G., CHAN, A.C.L., CHUNG, L.P., LOKE, S.L. and Ho, F.C.S., Evidence for lytic infection by Epstein-Barr virus in mucosal lymphocytes instead of nasopharyngeal epithelial cells in normal individuals. J. med. Virol., 45, 71-77 (1995b).
34. TIERNEY, R.J., STEVEN, N., YOUNG, L.S. and RICKINSON, A.B., Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J. Virol., 68, 7374-7385 (1994).
35. TRIVEDI, P., HU, L.F., CHEN, F., CHRISTENSSON, B., MASUCCI, M.G., KLEIN, G. and WINBERG, G., Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is nonimmunogenic in a murine model system, in contrast to a B-cell derived homologue. Europ. J. Cancer, 30A, 84-88 (1994).
36. TSAI, C.-N., LIU, S.-T. and CHANG, Y.-S., Identification of a novel promoter located within the BamHI Q region of the Epstein-Barr virus genome for the EBNA 1 gene. DNA Cell Biol., 14, 767-776 (1995).
37. WANG, D., LIEBOWITZ, D. and KIEFF, E., An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell, 43, 831-840 (1985).